Journal of Ginseng Research

The Korean Society of Ginseng (고려인삼학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Korean Red Ginseng Extract on Blood Circulation in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled Trial

건강한 지원자에서 홍삼농축액의 혈행 개선 효과: 무작위, 이중맹검, 위약-대조 시험

  • Published : 2007.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Korean red ginseng has broad efficacious effects against hypertension, diabetes, nociception, and cancer, and it counteracts weakness. It has been reported that Korean red ginseng is able to normalize blood pressure, improve cholesterol and lower blood glucose levels. We have recently reported that Korean red ginseng extract (KRGE) significantly prevented rat carotid arterial thrombosis in vivo, and inhibited platelet aggregation ex vivo and in vitro in a dose-dependent manner. The purpose of this study was to examine the effects of KRGE on blood circulation in human by measuring ex vivo platelet aggregation, plasma coagulation and serum lipid profiles in healthy volunteers. Subjects were randomly divided into three groups (placebo-group, KRGE-low dose group, KRGE-high dose group). Administration of KRGE to subjects significantly inhibited ADP-induced platelet aggregations both in KRGE-low dose group from $72.79{\pm}20.53$ to $62.00{\pm}23.06%$ (p=0.0009), and in KRGE-high dose group from $75.14{\pm}21.86$ to $64.52{\pm}24.72%$ (p=0.0039), respectively. Administration of KRGE to subjects also significantly inhibited collagen-induced platelet aggregations both in KRGE-low dose group from $85.52{\pm}12.57$ to $79.62{\pm}20.47%$ (p=0.0916), and in KRGE-high dose group from $80.24{\pm}18.11$ to $70.31{\pm}25.93%$ (p=0.0565), respectively. Whereas, KRGE has no significant effects on coagulation system, such as prothrombin time (PT) and activated partial thromboplastin time (APTT), and serum lipid profiles, such as total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol and triglyceride. KRGE also has no significant effects on hematological and serum biochemical profiles. These results suggest that KRGE has a potential to improve blood circulation through antiplatelet activity in human, and KRGE intake may be beneficial for the individuals with high risks of thrombotic and cardiovascular diseases.

Keywords

References

  1. 정진호: 혈행개선 관련 건강기능식품. 질환별로 본 건강기능 식품학, 한국약학대학협의회 위생약학분과회 저, 신일상사, 56-80 (2005)
  2. Farndale, R. W., Sixma, J. J., Barnes, M. J. and De Groot, P. G. : The role of collagen in thrombosis and hemostasis. J. Thromb. Haemost. 2, 561-573 (2004) https://doi.org/10.1111/j.1538-7836.2004.00665.x
  3. Gruner, S., Prostredna, M., Aktas, B., Moers, A., Schulte, V., Krieg, T., et al. : Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Circulation 110, 2946-2951 (2004) https://doi.org/10.1161/01.CIR.0000146341.63677.3C
  4. Sarratt, K. L., Chen, H., Kahn, M. L. and Hammer, D. A. : Platelet receptor glycoprotein VI-mediated adhesion to type I collagen under hydrodynamic flow. Ann. Biomed. Eng. 32, 970-976 (2004) https://doi.org/10.1023/B:ABME.0000032459.29696.65
  5. Sarratt, K. L., Chen, H., Zutter, M. M., Santoro, S. A., Hammer, D. A. and Kahn, M. L. : GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow. Blood 106, 1268-1277 (2005) https://doi.org/10.1182/blood-2004-11-4434
  6. Sherman, D. G. and Hart, R. G. : Thromboembolism and antithrombotic therapy in cerebrovascular disease. J. Am. Coll. Cardiol. 8, 88B-97B (1986) https://doi.org/10.1016/S0735-1097(86)80010-9
  7. Grande, P., Grauholt, A. M. and Madsen, J. K. : Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. Circulation 81, I16-9 (1990)
  8. Hjemdahl-Monsen, C. E., Lewis, H. D., Cairns, J., Chesebro, J. H. and Fuster, V. : Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. J. Am. Coll. Cardiol. 8, 67B-75B (1986) https://doi.org/10.1016/S0735-1097(86)80093-6
  9. Genton, E., Clagett, G. P. and Salzman, E. W.: Antithrombotic therapy in peripheral vascular disease. Chest 89, 75S-81S (1986) https://doi.org/10.1378/chest.89.1.75
  10. 남기열 외: 인삼제품, 홍삼제품의 기준 규격 및 기능성 재평가 적정성 검토. 식품의약품안전청(KFDA) 용역연구사업 보고서 (2004)
  11. Jin, Y. R., Yu, J. Y., Lee, J. J. and Yun, Y. P.: Antithrombotic and Antiplatelet Activities of Korean Red Ginseng Extract. Pharmacol. Toxicol. 100, 170-175 (2007)
  12. Han, G., Shin, I. C., Choi, K. J., Yun, Y. P., Hong, J. T., Oh, K. W. : Korea red ginseng water extract increases nitric oxide concentration in exhaled breath. Nitric Oxide 12, 159-162 (2005) https://doi.org/10.1016/j.niox.2005.02.001
  13. Lee, J. H. and Park, H. J. : Effects of Intaking of Red Ginseng Products on Human Platelet Aggregation and Blood Lipids. J. Ginseng Res. 22, 173-180 (1998)
  14. Lee, J. H. and Kim, S. H. : The Effect of the Long-Term Ginseng Intakes on Serum Lipids Profile and Hemostatic Factors in Human. Korean J. Nutrition 28(9), 862-871 (1995)
  15. 카네코 히토시, 마츠바라 야스히사, 우치다 히데오, 무시모토 미츠노리, 나카니시 코우소우, 마츠우라 아키히사, 타하라 미노루, 키시모토 요시오, 마츠모토 이사오 등: 고려삼분의 임상효과 검토 -제7보- 뇌동맥경화 환자에 대한 홍삼 캡슐의 검토. 임상과 연구 60(12), 170-176 (1983)

Cited by

  1. Ginseng for Health Care: A Systematic Review of Randomized Controlled Trials in Korean Literature vol.8, pp.4, 2013, https://doi.org/10.1371/journal.pone.0059978
  2. Safety Analysis of Panax Ginseng in Randomized Clinical Trials: A Systematic Review vol.2, pp.2, 2015, https://doi.org/10.3390/medicines2020106
  3. Protective effect of Korean red ginseng on oxaliplatin-mediated splenomegaly in colon cancer vol.95, pp.3, 2018, https://doi.org/10.4174/astr.2018.95.3.161
  4. Gene Level Interactions of Four Commonly Used Herbal Products-A Systematic Literature vol.18, pp.6, 2018, https://doi.org/10.3923/jbs.2018.307.316